ICON successfully acquired KCR, a contract research organization (CRO) with 27 years of experience in clinical development services, in August 2024.
KCR employs approximately 900 people across 14 countries and has expertise in over 20 therapeutic areas.
This strategic acquisition provides KCR with the resources and opportunities needed to accelerate its growth and development.
It also enhances both companies' capabilities in several key areas:
- Expanded service offerings: The acquisition strengthens ICON’s capacity in both full-service and functional service provision (FSP), offering more flexibility and tailored solutions for clients.
- Biotech expertise: KCR’s biotech division will integrate into ICON Biotech, reinforcing its leadership in this sector, with its dedicated team to biotech clients.
- Increased regional presence: KCR’s well established presence in Central and Eastern Europe enhances ICON’s operational capabilities in the region.
- Broader therapeutic expertise: KCR’s expertise in oncology, immunology, CNS, vaccines, and rare diseases complements ICON’s capabilities, enabling innovative solutions in these critical areas.
Both organizations share a commitment to building collaborative work environments and are united by strong values — accountability, collaboration, and a focus on delivering innovative solutions to clients.
Together, ICON and KCR are ensuring stability and continuity for customers as we move forward.
KCR clients will benefit from access to ICON’s expanded services portfolio, as well as increased expertise and scale in the clinical development space.
From molecule to medicine, ICON provides outsourced services to pharmaceutical, biotechnology, medical device, and public health organizations. Headquartered in Dublin, Ireland, ICON employs approximately 42,250 professionals across more than 50 countries.
This acquisition strengthens ICON’s ongoing commitment to delivering high-quality, patient-focused solutions and enhances our support for the global pharmaceutical, biotechnology, and medical device industries.
For more information on ICON's expanded services, visit iconplc.com.